← Leaderboards
Elizabeth E Brown
University Of Alabama At Birmingham
$15,628,362
Attributed
$19,720,438
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,720,438 · 14
By mechanism
R01$9,755,932 · 4
U01$5,845,222 · 2
P01$1,936,262 · 1
P30$926,861 · 4
R25$648,000 · 1
R21$608,161 · 2
Top collaborators
- Celine M Vachon10 shared
- Shaji Kunnathu Kumar5 shared
- Ralph D Sanderson2 shared
- Lalita A. Shevde2 shared
- Gareth John Morgan1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Maria Pisu$12,531,653
- Nita A Limdi$16,814,616
- James N. Odom$7,817,083
- A. Myriam Peralta-Carcelen$3,486,667
- Dorothy W. Pekmezi$4,444,616
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanMalignant NeoplasmsGenesResourcesEtiologyGeneticRaceEnvironmental Risk FactorInvestigationHigh RiskBaseInsightMortalityEpidemiologyPhenotypeEuropeanAffectEarly DiagnosisGenomicsMonitorComplexMorbidity - Disease RateCollaborationsPlay
Grant awards (56)
Impact of Genetic susceptibility along the continuum from MGUS to MM$659,222
U01 · FY2025 · CA
Epigenetic contribution to the excess risk of MGUS in African Americans$616,272
U01 · FY2025 · CA · contact PI
Role of Disadvantage, Mutographs and T Cell Immunity on MGUS in African Americans$509,510
R01 · FY2025 · CA · contact PI
Impact of Genetic susceptibility along the continuum from MGUS to MM$621,962
U01 · FY2024 · CA
Epigenetic contribution to the excess risk of MGUS in African Americans$585,460
U01 · FY2024 · CA · contact PI
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program$324,000
R25 · FY2024 · CA
04 - Cancer Control and Population Sciences$68,084
P30 · FY2024 · CA · contact PI
Impact of Genetic susceptibility along the continuum from MGUS to MM$650,438
U01 · FY2023 · CA
Epigenetic contribution to the excess risk of MGUS in African Americans$596,783
U01 · FY2023 · CA · contact PI
The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program$324,000
R25 · FY2023 · CA
04 - Cancer Control and Population Sciences$68,083
P30 · FY2023 · CA · contact PI
Impact of Genetic susceptibility along the continuum from MGUS to MM$694,881
U01 · FY2022 · CA
Epigenetic contribution to the excess risk of MGUS in African Americans$603,947
U01 · FY2022 · CA · contact PI
Characterization of the lupus nephritis microRNAome$509,974
R01 · FY2022 · AR · contact PI
Impact of Genetic susceptibility along the continuum from MGUS to MM (Supplement)$199,983
U01 · FY2022 · CA
04 - Cancer Control and Population Sciences$68,083
P30 · FY2022 · CA · contact PI
Epigenetic contribution to the excess risk of MGUS in African Americans$616,274
U01 · FY2021 · CA · contact PI
Characterization of the lupus nephritis microRNAome$511,515
R01 · FY2021 · AR · contact PI
06 Cancer Control and Population Sciences Program$35,199
P30 · FY2021 · CA · contact PI
Characterization of the lupus nephritis microRNAome$659,894
R01 · FY2020 · AR · contact PI
06 Cancer Control and Population Sciences Program$120,233
P30 · FY2020 · CA · contact PI
Characterization of the lupus nephritis microRNAome$660,896
R01 · FY2019 · AR · contact PI
06 Cancer Control and Population Sciences Program$117,307
P30 · FY2019 · CA · contact PI
06 Cancer Control and Population Sciences Program$8,695
P30 · FY2019 · CA · contact PI
Characterization of the lupus nephritis microRNAome$698,224
R01 · FY2018 · AR · contact PI
Association of genetic and autoantibody signatures with SLE clinical course$629,634
R01 · FY2018 · AR · contact PI
Molecular characterization of myeloma and related asymptomatic precursor states$263,388
R01 · FY2018 · CA · contact PI
06 Cancer Control and Population Sciences Program$97,930
P30 · FY2018 · CA · contact PI
06 Cancer Control and Population Sciences Program$8,649
P30 · FY2018 · CA · contact PI
06 Cancer Control and Population Sciences Program$3,965
P30 · FY2018 · CA · contact PI
06 Cancer Control and Population Sciences Program$2,264
P30 · FY2018 · CA · contact PI
06 Cancer Control and Population Sciences Program$1,978
P30 · FY2018 · CA · contact PI
Molecular characterization of myeloma and related asymptomatic precursor states$1,043,373
R01 · FY2017 · CA · contact PI
Association of genetic and autoantibody signatures with SLE clinical course$633,944
R01 · FY2017 · AR · contact PI
06 Cancer Control and Population Sciences Program$109,237
P30 · FY2017 · CA · contact PI
Association of genetic and autoantibody signatures with SLE clinical course$635,571
R01 · FY2016 · AR · contact PI
Molecular characterization of myeloma and related asymptomatic precursor states$431,508
R01 · FY2016 · CA · contact PI
06 Cancer Control and Population Sciences Program$30,429
P30 · FY2016 · CA · contact PI
06 Cancer Control and Population Sciences Program$8,694
P30 · FY2016 · CA · contact PI
Association of genetic and autoantibody signatures with SLE clinical course$636,211
R01 · FY2015 · AR · contact PI
Molecular characterization of myeloma and related asymptomatic precursor states$616,560
R01 · FY2015 · CA · contact PI
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma$136,172
R21 · FY2015 · CA · contact PI
Association of genetic and autoantibody signatures with SLE clinical course$673,703
R01 · FY2014 · AR · contact PI
Molecular characterization of myeloma and related asymptomatic precursor states$642,027
R01 · FY2014 · CA · contact PI
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma$124,966
R21 · FY2014 · CA · contact PI
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts$384,715
P01 · FY2012 · AR · contact PI
A genome-wide methylation study of epigenetic contributions to multiple myeloma$219,568
R21 · FY2012 · CA · contact PI
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts$340,967
P01 · FY2011 · AR · contact PI
A genome-wide methylation study of epigenetic contributions to multiple myeloma$127,455
R21 · FY2011 · CA · contact PI
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts$385,829
P01 · FY2010 · AR · contact PI
Functional Genomic Determinants of B cell Homeostasis and Susceptibility to SLE$24,490
P30 · FY2010 · AR · contact PI
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts$406,484
P01 · FY2009 · AR · contact PI
Functional Genomic Determinants of B cell Homeostasis and Susceptibility to SLE$56,337
P30 · FY2009 · AR · contact PI
A Genetic Risk Profile in Longitudinal Systemic Lupus Erythematosus (SLE) Cohorts$418,267
P01 · FY2008 · AR · contact PI
Functional Genomic Determinants of B cell Homeostasis and Susceptibility to SLE$53,704
P30 · FY2008 · AR · contact PI
Functional Genomic Determinants of B cell Homeostasis and Susceptibility to SLE$43,500
P30 · FY2007 · AR · contact PI